U.S. Markets open in 1 hr 30 mins

Pfizer launches Duchenne gene therapy study, joining Sarepta and Solid

Max Stendahl
American City Business Journals
Pfizer launches Duchenne gene therapy study, joining Sarepta and Solid

All three companies are developing drugs made up of a shortened version of the dystrophin gene, which normally protects muscle cells but is absent in boys with Duchenne.